Literature DB >> 3884416

Aorta and muscle metabolism in pigs with peripheral hyperinsulinaemia.

K Falholt, K G Alberti, L G Heding.   

Abstract

Peripheral hyperinsulinaemia usually found in conventionally treated Type 1 (insulin-dependent) diabetic patients may have deleterious metabolic effects. We have used a hyperinsulinaemic model to examine intermediary metabolism in two key peripheral tissues, aorta and muscle. Nine pigs were immunized with crystalline insulin. Subsequently, they showed an insulin-binding capacity of 86.2 +/- 25.0 pmol/l and fasting total serum insulin of 3.9 +/- 3.1 nmol/l (control range 0.034-0.072 nmol/l), impaired glucose tolerance after oral glucose tolerance testing, significantly elevated levels of peripheral venous serum free insulin and C-peptide, and increased mean post-prandial free insulin/glucose ratios. The immunized pigs showed marked elevation of aorta and muscle triglycerides compared with control pigs (n = 15) but similar levels of non-esterified fatty acids. The glucose-6-phosphate-dehydrogenase, malic enzyme and 3-hydroxyacyl-CoA-dehydrogenase activities were all increased significantly (by 50%-300%) in both aorta and muscle. Phosphofructokinase was decreased in both tissues. Hexokinase was increased in muscle alone whereas pyruvate kinase was significantly decreased in aorta. Glyceraldehyde-3-phosphate dehydrogenase activity was not significantly different in aorta and muscle. Thus in insulin immunized pigs with normal beta-cell function and pronounced peripheral hyperinsulinaemia there was increased peripheral lipogenic activity. These findings have potentially important implications with regard to macrovascular disease in diabetes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3884416     DOI: 10.1007/bf00276997

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  29 in total

1.  Radioimmunoelectrophoresis in the determination of insulin binding to IgG.

Authors:  A H Christiansen
Journal:  Horm Metab Res       Date:  1973-05       Impact factor: 2.936

2.  Metabolic changes in active chronic hepatitis.

Authors:  K G Alberti; C O Record; D H Williamson; R Wright
Journal:  Clin Sci       Date:  1972-05       Impact factor: 6.124

3.  Plasma free insulin profiles after administration of insulin by jet and conventional syringe injection.

Authors:  R Taylor; P D Home; K G Alberti
Journal:  Diabetes Care       Date:  1981 May-Jun       Impact factor: 19.112

4.  The immunogenicity of insulin preparation. Antibody levels before and after transfer to highly purified porcine insulin.

Authors:  L G Heding; Y Larsson; J Ludvigsson
Journal:  Diabetologia       Date:  1980       Impact factor: 10.122

5.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

6.  Diabetes and cardiovascular risk factors: the Framingham study.

Authors:  W B Kannel; D L McGee
Journal:  Circulation       Date:  1979-01       Impact factor: 29.690

7.  Hyperglycemia and arterial disease.

Authors:  H Keen; R J Jarrett; J H Fuller; P McCartney
Journal:  Diabetes       Date:  1981       Impact factor: 9.461

8.  Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.

Authors:  J H Fuller; M J Shipley; G Rose; R J Jarrett; H Keen
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

9.  Exercise in diabetic man: glucose turnover and free insulin responses after glycemic normalization with intravenous insulin.

Authors:  B Zinman; E B Marliss; A K Hanna; H L Minuk; M Vranic
Journal:  Can J Physiol Pharmacol       Date:  1982-10       Impact factor: 2.273

10.  Free insulin, C-peptide and glucagon profiles in insulin dependent diabetes mellitus.

Authors:  R S Scott; E A Espiner; R A Donald; M J Ellis
Journal:  Aust N Z J Med       Date:  1980-04
View more
  3 in total

Review 1.  The biochemistry of diabetes.

Authors:  R Taylor; L Agius
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

Review 2.  When to use insulin in the maturity onset diabetic.

Authors:  R B Tattersall; A R Scott
Journal:  Postgrad Med J       Date:  1987-10       Impact factor: 2.401

3.  Insulin for the non-insulin dependent?

Authors:  R Taylor
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.